The meeting features the latest findings related to the genomic basis of rare diseases, which can provide powerful insights into human biology. As we move beyond exome sequencing to whole genome sequencing, the opportunities and challenges that arise for human genome analysis and clinical practice will also be explored.
This year's meeting will focus on the links between monogenic and polygenic disorders and will explore the various modifiers of rare disease. We will discuss new technologies, including metabolomic approaches. We plan an extended session on new approaches to therapy and will also debate current ethical issues in genomic medicine.
Scientific sessions:
Monogenic meets polygenic disease
Modifiers of rare disease
Metabolomics
New technology
Matchmaking exomes: the lonely variant
New approaches to therapy
Ethical and policy issues in genomic medicine
We welcome abstracts from all areas relevant to the main themes of the meeting, for both oral and poster presentations. Several oral presentations will be chosen from the abstracts submitted.
Please get in touch for further information on sponsorship and exhibition packages.
This year's meeting will focus on the links between monogenic and polygenic disorders and will explore the various modifiers of rare disease. We will discuss new technologies, including metabolomic approaches. We plan an extended session on new approaches to therapy and will also debate current ethical issues in genomic medicine.
Scientific sessions:
Monogenic meets polygenic disease
Modifiers of rare disease
Metabolomics
New technology
Matchmaking exomes: the lonely variant
New approaches to therapy
Ethical and policy issues in genomic medicine
We welcome abstracts from all areas relevant to the main themes of the meeting, for both oral and poster presentations. Several oral presentations will be chosen from the abstracts submitted.
Please get in touch for further information on sponsorship and exhibition packages.
